Company attributes
Industry
Location
B2X
Legal Name
MyoNexus Therapeutics, Inc.
Legal classification
Spun Out From
Number of Employees (Ranges)
11 – 50
Full Address
8000 Walton Parkway Suite 255 New Albany, OH 43054 United States
Founded Date
January 1, 2017
Total Funding Amount (USD)
62,500,000
Latest Funding Round Date
May 8, 2018
Acquisition Transaction
Latest Funding Type
Country
Other attributes
Acquirer
Company Operating Status
Active
Myonexus Therapeutics is a clinical stage gene therapy company developing treatments for Limb-girdle muscular dystrophy based on research at Nationwide Children's Hospital. The company was acquired by Sarepta for $165 million in February of 2019.
Timeline
No Timeline data yet.
Funding Rounds
Products
Acquisitions
SBIR/STTR Awards
Patents
Further Resources
No Further Resources data yet.
